Latest headlines

Novo Nordisk A/S News

Q: Why is Novo Nordisk A/S up or down today?

Novo Nordisk A/S (NVO) moves on news. The headlines above show what is driving NVO today; cross-check the reaction against its Fear and Greed Index and trading volume.

Q: How often is Novo Nordisk A/S news updated?

The Novo Nordisk A/S (NVO) news feed refreshes continuously as new stories are published.

Q: How does Novo Nordisk A/S news relate to its Fear and Greed Index?

News drives sentiment and sentiment drives price. Read Novo Nordisk A/S news alongside its Fear and Greed Index to separate noise from a real shift in mood.

The latest Novo Nordisk A/S (NVO) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these NVO headlines next to the live Novo Nordisk A/S Fear and Greed Index.

Latest Novo Nordisk A/S Headlines57

Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip?

fool.com · Jul 31, 2026

Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed.

fool.com · Jul 31, 2026

Why Is BioAge Labs Stock Sinking Friday?

benzinga.com · Jul 31, 2026

Weight Loss Drug Stocks Novo Nordisk, Eli Lilly Slump Below Key Levels

investors.com · Jul 31, 2026

Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial

forbes.com · Jul 31, 2026

Novo Nordisk Stock Drops as Heart Drug Fails Late-Stage Trial

barrons.com · Jul 31, 2026

Novo Nordisk's stock slumps after failed trial — adding to the company's woes

marketwatch.com · Jul 31, 2026

Novo Nordisk Says Anti-Inflammatory Drug Trial Fails to Cut Cardiovascular Risk in High Risk Patients

benzinga.com · Jul 31, 2026

Novo Nordisk Stock Sinks on Disappointing Heart Drug Trial Results

investopedia.com · Jul 31, 2026

Novo Nordisk Stock Tumbles on Late-Stage Trial Results

schaeffersresearch.com · Jul 31, 2026

Novo Nordisk Shares Drop After Drug Candidate Fails in Cardiovascular Trial

wsj.com · Jul 31, 2026

Novo Nordisk shares dive 9% after heart medicine fails trial

cnbc.com · Jul 31, 2026

Novo Nordisk's inflammation drug fails to reduce cardiovascular risk in trial

reuters.com · Jul 31, 2026

3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold

fool.com · Jul 29, 2026

How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q2 Results?

zacks.com · Jul 29, 2026

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

cnbc.com · Jul 29, 2026

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

fool.com · Jul 29, 2026

Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing

zacks.com · Jul 28, 2026

Novo Nordisk must face US shareholder lawsuit over CagriSema clinical trial

reuters.com · Jul 28, 2026

Where Will Novo Nordisk Stock Be in 3 Years?

fool.com · Jul 28, 2026

Novo Nordisk: Sensitivity Analysis Of Oral Wegovy's Gross Profits Supports Modest Buy

seekingalpha.com · Jul 27, 2026

Novo Nordisk Remains A Generational Buying Opportunity Ahead Of Q2 Earnings

seekingalpha.com · Jul 27, 2026

Novo Nordisk: Initiating Buy, Calling The Bottom

seekingalpha.com · Jul 26, 2026

Novo Nordisk: Mr. Market Is Pricing In Success, But It's Too Early To Bank On That

seekingalpha.com · Jul 26, 2026

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?

fool.com · Jul 24, 2026

As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize

barrons.com · Jul 24, 2026

Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads

wsj.com · Jul 24, 2026

Novo Nordisk seeks preliminary injunction against Lilly weight-loss ads

reuters.com · Jul 24, 2026

3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

fool.com · Jul 23, 2026

Crux Collaborates with Novo Nordisk to Offer Access to Wegovy® and Other Obesity Management Medications

businesswire.com · Jul 23, 2026

Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says

cnbc.com · Jul 23, 2026

Weight loss drugs linked to increase risk of hair loss

news.sky.com · Jul 22, 2026

Here's Why Novo Nordisk (NVO) Fell More Than Broader Market

zacks.com · Jul 22, 2026

Novo Resources Releases Updated Corporate Presentation

globenewswire.com · Jul 22, 2026

NVO Challenges LLY Ads in GLP-1 Battle: Why the Lawsuit Matters Now

zacks.com · Jul 22, 2026

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

fool.com · Jul 22, 2026

"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly.

fool.com · Jul 21, 2026

Novo Nordisk sues Eli Lilly over GLP-1 drug advertising claims

proactiveinvestors.com · Jul 21, 2026

GLP-1 Titans Clash: Comparing Eli Lilly and Novo Nordisk

zacks.com · Jul 21, 2026

Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising

barrons.com · Jul 21, 2026

Novo Sues Rival Lilly Over Weight-Loss Ads

youtube.com · Jul 21, 2026

Is Most-Watched Stock Novo Nordisk A/S (NVO) Worth Betting on Now?

zacks.com · Jul 21, 2026

Popular Drug Maker Slams GLP-1 Peer on False Advertising

schaeffersresearch.com · Jul 21, 2026

Novo Nordisk Sues GLP-1 Rival Eli Lilly For Misleading Advertising

forbes.com · Jul 21, 2026

Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing

fool.com · Jul 21, 2026

Nasdaq Futures Jump 357 Points as Earnings Season Heats Up

schaeffersresearch.com · Jul 21, 2026

Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

invezz.com · Jul 21, 2026

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

marketwatch.com · Jul 21, 2026

Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugs

wsj.com · Jul 21, 2026

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

reuters.com · Jul 21, 2026

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

cnbc.com · Jul 21, 2026

Novo Nordisk's Rally Has Room To Run Driven By Oral Wegovy's Momentum

seekingalpha.com · Jul 20, 2026

Does EU Approval of Wegovy Pill Change NVO's Competitive Story?

zacks.com · Jul 20, 2026

Citi lifts Novo Nordisk target on strong GLP-1 pill launch

proactiveinvestors.com · Jul 20, 2026

Citi lifts Novo Nordisk target on strong GLP-1 pill launch

proactiveinvestors.co.uk · Jul 20, 2026

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1

fool.com · Jul 18, 2026

AI Bubble Risks Make Dividend Stocks Attractive Again

seekingalpha.com · Jul 18, 2026

Why Is Novo Nordisk A/S Up or Down Today?

When Novo Nordisk A/S (NVO) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a NVO move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Novo Nordisk A/S is up or down today.

How Novo Nordisk A/S News Affects the Price

News does not move the Novo Nordisk A/S (NVO) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Novo Nordisk A/S Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Novo Nordisk A/S trading volume. That is the chain to watch: headline, sentiment, volume, then the NVO price.

Trade the Novo Nordisk A/S News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Novo Nordisk A/S trading volume spike on a big story, check the Novo Nordisk A/S price history for context, follow the live NVO price, see the Novo Nordisk A/S price prediction, and read the Novo Nordisk A/S Fear and Greed Index for mood.

How do you feel about Novo Nordisk A/S?

Frequently asked questions

Why is Novo Nordisk A/S up or down today?

Novo Nordisk A/S (NVO) moves on news, and the headlines above are the fastest way to see what is driving NVO today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Novo Nordisk A/S Fear and Greed Index and NVO trading volume.

What is the latest Novo Nordisk A/S news?

The newest Novo Nordisk A/S (NVO) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent NVO news cycle in one place.

Where does Novo Nordisk A/S news come from?

We aggregate Novo Nordisk A/S (NVO) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.

How often is Novo Nordisk A/S news updated?

Continuously. The Novo Nordisk A/S (NVO) feed refreshes as new stories are published, so the headlines at the top are the freshest available.

How does Novo Nordisk A/S news relate to its Fear and Greed Index?

News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Novo Nordisk A/S Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.